This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): TRPV4 program
Description: Hydra is developing a TRPV4 program for pulmonary, metabolic disorders, and genetic diseases.
TRPV4 program News
Additional information available to subscribers only: